Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.

K Hoschler; S Maharjan; H Whitaker; J Southern; B Okai; J Baldevarona; PJ Turner; NJ Andrews; E Miller; M Zambon

doi:10.1016/j.vaccine.2020.02.024

Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.

K Hoschler, S Maharjan, H Whitaker, J Southern, B Okai, J Baldevarona, PJ Turner, NJ Andrews, E Miller, M Zambon

Research output: Contribution to journal › Article › peer-review

Original language	Undefined/Unknown
Journal	Vaccine
DOIs	https://doi.org/10.1016/j.vaccine.2020.02.024
Publication status	Published - Feb 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2020.02.024

Cite this

@article{4db2dcaf24d54ee4b3feeede1f8232b6,

title = "Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.",

author = "K Hoschler and S Maharjan and H Whitaker and J Southern and B Okai and J Baldevarona and PJ Turner and NJ Andrews and E Miller and M Zambon",

year = "2020",

month = feb,

doi = "10.1016/j.vaccine.2020.02.024",

language = "Undefined/Unknown",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.

AU - Hoschler, K

AU - Maharjan, S

AU - Whitaker, H

AU - Southern, J

AU - Okai, B

AU - Baldevarona, J

AU - Turner, PJ

AU - Andrews, NJ

AU - Miller, E

AU - Zambon, M

PY - 2020/2

Y1 - 2020/2

UR - http://europepmc.org/abstract/med/32070679

U2 - 10.1016/j.vaccine.2020.02.024

DO - 10.1016/j.vaccine.2020.02.024

M3 - Article

C2 - 32070679

SN - 0264-410X

JO - Vaccine

JF - Vaccine

ER -

Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.

UN SDGs

Access to Document

Other files and links

Cite this